These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37546914)
1. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Jin Y; Basu S; Feng M; Ning Y; Munasinghe I; Joachim AM; Li J; Madden R; Burks H; Gao P; Perera C; Werbovetz KA; Zhang K; Wang MZ Res Sq; 2023 Jul; ():. PubMed ID: 37546914 [TBL] [Abstract][Full Text] [Related]
2. CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles. Jin Y; Basu S; Feng M; Ning Y; Munasinghe I; Joachim AM; Li J; Qin L; Madden R; Burks H; Gao P; Wu JQ; Sheikh SW; Joice AC; Perera C; Werbovetz KA; Zhang K; Wang MZ Nat Commun; 2024 Oct; 15(1):9409. PubMed ID: 39482311 [TBL] [Abstract][Full Text] [Related]
3. N-substituted-4-(pyridin-4-ylalkyl)piperazine-1-carboxamides and related compounds as Leishmania CYP51 and CYP5122A1 inhibitors. La Rosa C; Sharma P; Junaid Dar M; Jin Y; Qin L; Roy A; Kendall A; Wu M; Lin Z; Uchenik D; Li J; Basu S; Moitra S; Zhang K; Zhuo Wang M; Werbovetz KA Bioorg Med Chem; 2024 Nov; 113():117907. PubMed ID: 39288704 [TBL] [Abstract][Full Text] [Related]
4. Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway. Feng M; Jin Y; Yang S; Joachim AM; Ning Y; Mori-Quiroz LM; Fromm J; Perera C; Zhang K; Werbovetz KA; Wang MZ Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():27-42. PubMed ID: 35994895 [TBL] [Abstract][Full Text] [Related]
5. Molecular Characterization of Sterol C4-Methyl Oxidase in Ning Y; Basu S; Hsu FF; Feng M; Wang MZ; Zhang K Int J Mol Sci; 2024 Oct; 25(20):. PubMed ID: 39456689 [TBL] [Abstract][Full Text] [Related]
6. Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1. Pandharkar T; Zhu X; Mathur R; Jiang J; Schmittgen TD; Shaha C; Werbovetz KA Antimicrob Agents Chemother; 2014 Aug; 58(8):4682-9. PubMed ID: 24890590 [TBL] [Abstract][Full Text] [Related]
7. CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani. Verma S; Mehta A; Shaha C PLoS One; 2011; 6(9):e25273. PubMed ID: 21966477 [TBL] [Abstract][Full Text] [Related]
8. An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy. Emami S; Tavangar P; Keighobadi M Eur J Med Chem; 2017 Jul; 135():241-259. PubMed ID: 28456033 [TBL] [Abstract][Full Text] [Related]
10. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. Jain SK; Sahu R; Walker LA; Tekwani BL J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097 [TBL] [Abstract][Full Text] [Related]
11. Repurposing azole antifungals into antileishmanials: Novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Keighobadi M; Emami S; Fakhar M; Shokri A; Mirzaei H; Hosseini Teshnizi S Parasitol Int; 2019 Apr; 69():103-109. PubMed ID: 30582997 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl Linker. Abdelhameed A; Feng M; Joice AC; Zywot EM; Jin Y; La Rosa C; Liao X; Meeds HL; Kim Y; Li J; McElroy CA; Wang MZ; Werbovetz KA ACS Infect Dis; 2021 Jul; 7(7):1901-1922. PubMed ID: 33538576 [TBL] [Abstract][Full Text] [Related]
13. Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. Chen CK; Leung SS; Guilbert C; Jacobson MP; McKerrow JH; Podust LM PLoS Negl Trop Dis; 2010 Apr; 4(4):e651. PubMed ID: 20386598 [TBL] [Abstract][Full Text] [Related]
14. Ultrastructural Investigation of Shokri A; Fakhar M; Emami S; Gill P; Akhtari J Recent Pat Antiinfect Drug Discov; 2018; 13(3):246-255. PubMed ID: 30227826 [TBL] [Abstract][Full Text] [Related]
16. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes. Kumar V; Kumari S; Ranjan R; Kumar A; Alti D Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765 [TBL] [Abstract][Full Text] [Related]
17. Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum. Hargrove TY; Wawrzak Z; Liu J; Nes WD; Waterman MR; Lepesheva GI J Biol Chem; 2011 Jul; 286(30):26838-48. PubMed ID: 21632531 [TBL] [Abstract][Full Text] [Related]
18. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies. Shokri A; Abastabar M; Keighobadi M; Emami S; Fakhar M; Teshnizi SH; Makimura K; Rezaei-Matehkolaei A; Mirzaei H J Glob Antimicrob Resist; 2018 Sep; 14():260-265. PubMed ID: 29793051 [TBL] [Abstract][Full Text] [Related]
19. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa. Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838 [TBL] [Abstract][Full Text] [Related]